Phreesia Inc.

American healthcare software company

PHR NYSE ISIN US71944F1066 SEC CIK 1412408
Follow Phreesia Weekly email: filings, results

Financials

Reported figures only · latest: Q2 2027 USD · US GAAP
Revenue, last quarter $129.5M +10.4% vs same quarter last year
Net income $1.9M +193.3% vs same quarter last year
EPS, diluted $0.03 +200% vs same quarter last year
Operating cash flow $18.3M +23.5% vs same quarter last year
Revenue by quarter
$106.8M
$100.4M
$115.9M
$117.3M
$120.3M
$114.3M
$130.9M
$129.5M
Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27 Q2 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400M$600MFY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$467.8M$2.3M
FY25$410.5M−$58.5M
FY24$346M−$136.9M
FY23$280.9M−$176.1M
FY22$213.2M−$118.2M
FY21$148.7M−$27.3M
FY20$124.8M−$20.3M
FY19$99.9M−$15.1M
FY18$79.8M−$18.2M
FY17--
MarginsShare of revenue
  • Operating margin
  • Net margin
−80%−60%−40%−20%0%20%FY18FY20FY22FY24FY26
Show the numbers
YearOperating marginNet margin
FY26−1.4%0.5%
FY25−14.2%−14.3%
FY24−39.4%−39.6%
FY23−62.9%−62.7%
FY22−54.8%−55.4%
FY21−17.3%−18.4%
FY20−12.3%−16.3%
FY19−9.5%−15.1%
FY18−18.2%−22.8%
FY17--
Free cash flowOperating cash flow minus capital expenditure
−$100M−$50M$0$50M$100MFY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26$67.7M
FY25$23.7M
FY24−$38.2M
FY23−$94.9M
FY22−$93.1M
FY21−$8.4M
FY20−$6.2M
FY19−$6.9M
FY18−$17.7M
FY17-
Net margin vs the sectorMedian of Industrials companies filing with the SEC
  • Phreesia
  • Industrials median
−80%−60%−40%−20%0%20%FY18FY20FY22FY24FY26
Show the numbers
YearPhreesiaIndustrials median
FY260.5%1.9%
FY25−14.3%2.5%
FY24−39.6%3.3%
FY23−62.7%3.7%
FY22−55.4%3.8%
FY21−18.4%3.7%
FY20−16.3%0.3%
FY19−15.1%3.8%
FY18−22.8%3.9%
FY17-4%